U.S. flag

An official website of the Department of Health and Human Services

SHARE:

FacebookTwitterEmail AHRQPrintShare

Search EPC Reports

 

Topic

Publication Date

Report Type

Report Affiliation(s)

Report Status

Search Evidence-based Practice Center Reports

Sign up: Sign up for email updates Evidence-Based Practice Email updates

Evidence-based Practice Center (EPC) reports offer comprehensive, science-based information on common or costly medical conditions and new healthcare technologies and strategies. Your search results cover complete titles of all evidence reports released by the EPCs, including reports for the Effective Health Care Program, the Technology Assessment Program, and the U.S. Preventive Services Task Force.

Results

1-18 of 18 Evidence Based Reports Found
Use of Natriuretic Peptide Measurement in the Management of Heart Failure
Date: November 2013
Report Type: Comparative Effectiveness Reviews
Affiliation: McMaster University
Report Status: Final
Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
Date: September 2013
Report Type: Comparative Effectiveness Reviews
Affiliation: Tufts University
Report Status: Final
Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
Date: July 2013
Report Type: U.S. Preventive Services Task Force Evidence Syntheses
Affiliation: Pacific Northwest EPC—Oregon Health & Science University
Report Status: Final
PCA3 Testing for the Diagnosis and Management of Prostate Cancer
Date: April 2013
Report Type: Comparative Effectiveness Reviews
Affiliation: Blue Cross/Blue Shield Association Technology Evaluation Center
Report Status: Final
Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin
Date: February 2013
Report Type: Technology Assessment Program Reports
Affiliation: RTI International—University of North Carolina at Chapel Hill
Report Status: Final
Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer
Date: February 2013
Report Type: Technology Assessment Program Reports
Affiliation: Tufts University
Report Status: Final
Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer
Date: December 2012
Report Type: Technical Briefs
Affiliation: Blue Cross/Blue Shield Association Technology Evaluation Center
Report Status: Final
Procalcitonin-Guided Antibiotic Therapy
Date: October 2012
Report Type: Comparative Effectiveness Reviews
Affiliation: Blue Cross/Blue Shield Association Technology Evaluation Center
Report Status: Final
Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias
Date: August 2012
Report Type: Comparative Effectiveness Reviews
Affiliation: Tufts University
Report Status: Final
Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults
Date: February 2012
Report Type: Comparative Effectiveness Reviews
Affiliation: Pacific Northwest EPC—Oregon Health & Science University
Report Status: Final
Assessment of Thiopurine Methyltransferase Activity in Patients Prescribed Azathioprine or Other Thiopurine-based Drugs
Date: December 2010
Report Type: Evidence Reports
Affiliation: University of Ottawa
Report Status: Final
Quality, Regulation and Clinical Utility of Laboratory-developed Molecular Tests
Date: October 2010
Report Type: Technology Assessment Program Reports
Affiliation: ECRI Institute—Penn Medicine
Report Status: Final
Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Date: June 2010
Report Type: Technology Assessment Program Reports
Affiliation: Tufts University
Report Status: Final
Genetic Tests for Non-Cancer Diseases/Conditions: A Horizon Scan
Date: March 2010
Report Type: Technology Assessment Program Reports
Affiliation: Tufts University
Report Status: Final
A systematic review of loss-of-heterozygosity based topographic genotyping with PathfinderTG®
Date: March 2010
Report Type: Technology Assessment Program Reports
Affiliation: Tufts University
Report Status: Final
Reviews of Selected Pharmacogenetic Tests for Non-Cancer and Cancer Conditions
Date: November 2008
Report Type: Technology Assessment Program Reports
Affiliation: Tufts University
Report Status: Final
Meta-regression Approaches: What, Why, When, and How?
Date: October 2004
Report Type: Technical Briefs
Affiliation: Southern California EPC—RAND Corporation
Report Status: Final
Lung Cancer Screening
Date: May 2004
Report Type: U.S. Preventive Services Task Force Evidence Syntheses
Affiliation: Pacific Northwest EPC—Oregon Health & Science University
Report Status: Final